Table 4 Recommendations for screening [18]

Primary prevention

All adults ≥ 40 years, however earlier screening at the age of 20 years can be considered

Secondary prevention

All patients with ASCVD, (e.g., CAD, CVD, PAD), or multiple major risk factors

Family history of early CVD or familial dyslipidemia

As early as the second year of life